NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Honeywell shares jumped on Thursday after the industrial conglomerate capped off 2025 with a strong fourth quarter and moved up its aerospace spinoff.Read More